Has the UK really legalised medical cannabis? That was certainly how it was reported last winter when Sajid Javid, the Home Secretary, overhauled government policy to give more UK patients access to cannabis-based medicines.
But now the groups that lobbied for those changes – and the parliamentarians that support them – say the new scheme is a disappointment, benefiting only a tiny number of patients.
What’s really going on? That was the question that kicked off yesterday’s Spectator cannabis briefing which brought together practitioners, politicians and legal experts to get to the bottom of cannabis policy in Britain. What’s changed? Who benefits? And where will it go next?